Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ansari

Showing results (161-170 of 195) with videos related to

Pageof 20
Sort By:
British Journal of Haematology|February 4, 2020
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 childrenTheodor Uden, Alice Bertaina, Jonas Abrahamsson, et al.
The Lancet. Oncology|November 26, 2016
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International CollaborationRebecka L Meyers, Rudolf Maibach, Eiso Hiyama, et al.
Oncotarget|December 7, 2017
GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter studyMarc Ansari, Patricia Huezo-Diaz Curtis, Chakradhara Rao S Uppugunduri, et al.
Hematological Oncology|December 7, 2023
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021Jakob R Passweg, Helen Baldomero, Marc Ansari, et al.
Eclinicalmedicine|September 23, 2024
Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration databaseEiso Hiyama, Tomoro Hishiki, Kenichi Yoshimura, et al.
Drug Delivery|May 2, 2026
Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic reviewAmirhossein Masroor, Nienke Streefkerk, Martine Van Grotel, et al.
The New England Journal of Medicine|June 21, 2018
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing LossPenelope R Brock, Rudolf Maibach, Margaret Childs, et al.
Blood Advances|March 4, 2026
Refining Busulfan Exposure Enhances Pediatric ALL HSCT Outcomes: Insights from the International FORUM StudyKhalil Ben Hassine, Yvonne Sylvia Gloor, Isabelle Dupanloup, et al.
Bone Marrow Transplantation|July 3, 2021
Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCTMarc Ansari, Kateryna Petrykey, Mohamed Aziz Rezgui, et al.
BMJ Open|November 29, 2024
Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)Jerome Stirnemann, Jacques Serratrice, Tamara Mann, et al.
Pageof 20

Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|February 4, 2020
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 childrenTheodor Uden, Alice Bertaina, Jonas Abrahamsson, et al.
The Lancet. Oncology|November 26, 2016
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International CollaborationRebecka L Meyers, Rudolf Maibach, Eiso Hiyama, et al.
Oncotarget|December 7, 2017
GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter studyMarc Ansari, Patricia Huezo-Diaz Curtis, Chakradhara Rao S Uppugunduri, et al.
Hematological Oncology|December 7, 2023
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021Jakob R Passweg, Helen Baldomero, Marc Ansari, et al.
Eclinicalmedicine|September 23, 2024
Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration databaseEiso Hiyama, Tomoro Hishiki, Kenichi Yoshimura, et al.
Drug Delivery|May 2, 2026
Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic reviewAmirhossein Masroor, Nienke Streefkerk, Martine Van Grotel, et al.
The New England Journal of Medicine|June 21, 2018
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing LossPenelope R Brock, Rudolf Maibach, Margaret Childs, et al.
Blood Advances|March 4, 2026
Refining Busulfan Exposure Enhances Pediatric ALL HSCT Outcomes: Insights from the International FORUM StudyKhalil Ben Hassine, Yvonne Sylvia Gloor, Isabelle Dupanloup, et al.
Bone Marrow Transplantation|July 3, 2021
Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCTMarc Ansari, Kateryna Petrykey, Mohamed Aziz Rezgui, et al.
BMJ Open|November 29, 2024
Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)Jerome Stirnemann, Jacques Serratrice, Tamara Mann, et al.
Pageof 20